Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13031
Title: Transient hypoxaemia during neutrophil recovery in febrile patients.
Austin Authors: White, K;Cebon, Jonathan S 
Affiliation: Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Hospital, Heidelberg, Australia
Issue Date: 22-Apr-1995
Publication information: Lancet (london, England); 345(8956): 1022-4
Abstract: In previous anecdotal reports, treatment with granulocyte colony-stimulating factor has been associated with pulmonary toxicity. In 35 consecutive admissions for chemotherapy-induced febrile neutropenia, transient hypoxia occurred in 12. 10 of the 12 followed treatment with filgrastim to induce neutrophil recovery. There was no consistent association with cytotoxic regimen.
Gov't Doc #: 7536871
URI: https://ahro.austin.org.au/austinjspui/handle/1/13031
Journal: Lancet
URL: https://pubmed.ncbi.nlm.nih.gov/7536871
Type: Journal Article
Subjects: Adolescent
Adult
Anoxia.etiology
Fever.complications.drug therapy
Granulocyte Colony-Stimulating Factor.therapeutic use
Humans
Male
Middle Aged
Neutropenia.complications.drug therapy
Recombinant Proteins.therapeutic use
Appears in Collections:Journal articles

Show full item record

Page view(s)

18
checked on Sep 26, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.